Investors

AIM Rule 26

This area of the web site contains all information which is required to be disclosed in accordance with Rule 26 of the AIM Rules.

Description of Business:

Names of the directors and biographical details:

Responsibilities of the members of the board:

Country of incorporation / operation:

Current Constitutional documents:

Shareholder Information:

  • Number of AIM securities in issue
  • Significant shareholders
  • Shares not in public hands
  • Restriction in transfer of AIM Securities
  • Shareholder Rights
  • UK City Code on Takeovers and Mergers

Financial information:

Company announcements:

Admission document:

Advisers:

see Advisers

 

 
Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products
Biodose Intelligent Medication Management